Physician profile
Constance Marks
NPI 1831398445
$11,739.71
in general payments reported to CMS, 2019-2025
55 companies · $2,580 in 2025
The $2,580 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,880 · 2020: $606 · 2021: $1,192 · 2022: $2,304 · 2023: $1,521 · 2024: $1,658 · 2025: $2,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,724 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,723.75 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,066.42 | 2019-2025 | Lithovue, Ams 700, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $887.78 | 2019-2024 | Xtandi, Myrbetriq |
| Axonics, INC. | $767.46 | 2021-2023 | Axonics |
| Dendreon Pharmaceuticals LLC | $667.48 | 2019-2025 | Provenge |
| Olympus America INC. | $625.38 | 2021-2025 | Itind System, Soltive |
| Abbvie INC. | $587.12 | 2019-2025 | |
| Coloplast Corp | $442.28 | 2019-2025 | |
| Janssen Biotech, INC. | $391.27 | 2019-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $333.92 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $275.23 | 2023-2025 | Prolaris, Myrisk |
| Sumitomo Pharma America, INC. | $270.36 | 2024-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $254.03 | 2021-2025 | |
| Verity Pharmaceuticals INC. | $244.78 | 2022-2024 | Trelstar |
| Astrazeneca Pharmaceuticals Lp | $194.28 | 2020-2025 | Lynparza, Imfinzi |
| Endo Pharmaceuticals INC. | $178.57 | 2019-2023 | Edex, Aveed, Xiaflex |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $178.46 | 2019-2025 | Adstiladrin |
| Myovant Sciences INC. | $154.61 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $137.37 | 2022-2025 | |
| Tolmar, INC. | $129.44 | 2024-2025 | Eligard |
| Teleflex LLC | $124.52 | 2023-2024 | Urolift |
| Endo USA, INC. | $121.25 | 2024-2025 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $112.19 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Rochester Medical Corporation | $101.06 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $97.93 | 2021-2025 | Pylarify |
| Accord Healthcare, INC. | $96.47 | 2022-2024 | |
| Antares Pharma, INC. | $91.09 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Pacira Pharmaceuticals Incorporated | $90.32 | 2021 | |
| Merck Sharp & Dohme LLC | $83.85 | 2020-2024 | Keytruda, Lynparza, Welireg |
| Allergan, INC. | $77.22 | 2019-2021 | |
| Immunitybio, INC. | $73.34 | 2025 | |
| Blue Earth Diagnostics | $72.73 | 2020-2022 | |
| Baxter Healthcare | $62.86 | 2022 | |
| Genzyme Corporation | $62.70 | 2020-2022 | |
| Valencia Technologies Corporation | $61.98 | 2025 | Ecoin Device Kit |
| Tempus Ai, INC | $55.10 | 2024 | |
| Pfizer INC. | $53.55 | 2025 | |
| Halozyme INC | $52.90 | 2023 | |
| Urovant Sciences INC | $50.88 | 2021-2022 | |
| Telix Pharmaceuticals | $48.60 | 2023-2025 | Illuccix |
| Caldera Medical, INC | $38.65 | 2021 | |
| Travere Therapeutics, INC. | $36.22 | 2019-2020 | |
| Amniox Medical, INC. | $35.00 | 2019 | |
| Hollister Incorporated | $34.02 | 2023 | Onli, Infyna Chic, Vapro Plus Pocket |
| Convatec INC. | $29.96 | 2023 | |
| Cardinal Health 414 LLC | $25.27 | 2022 | |
| Azurity Pharmaceuticals, INC. | $23.87 | 2025 | Azmiro |
| 180 Medical, INC. | $19.95 | 2021 | |
| Medtronic, INC. | $19.67 | 2022 | |
| Calyxo, INC. | $17.85 | 2024 | Cvac Aspiration System |
| Foundation Medicine, INC. | $17.20 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $14.13 | 2025 | |
| Avation Medical, INC. | $14.06 | 2025 | Vivally System |
| Janssen Scientific Affairs, LLC | $13.61 | 2019 | |
| Amgen INC. | $11.77 | 2021 | |
| Mission Pharmacal Company | $11.70 | 2023 | Uribel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constance Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.